Introduction of new vaccines for immunization in pregnancy – Programmatic, regulatory, safety and ethical considerations
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Date
2019-05-31Journal
VaccinePublisher
Elsevier Ltd.Type
Article
Metadata
Show full item recordAbstract
Immunizing pregnant women is a promising strategy to reduce infectious disease-related morbidity and mortality in pregnant women and their infants. Important pre-requisites for the successful introduction of new vaccines for immunization in pregnancy include political commitment and adequate financial resources: trained, committed and sufficient numbers of healthcare workers to deliver the vaccines; close integration of immunization programs with antenatal care and Maternal and Child Health services; adequate access to antenatal care by pregnant women in the country (especially in low and middle-income countries (LMIC)); and a high proportion of births occurring in health facilities (to ensure maternal and neonatal follow-up can be done). The framework needed to advance a vaccine program from product licensure to successful country-level implementation includes establishing and organizing evidence for anticipated vaccine program impact, developing supportive policies, and translating policies into local action. International and national coordination efforts, proactive planning from conception to implementation of the programs (including country-level policy making, planning, and implementation, regulatory guidance, pharmacovigilance)and country-specific and cultural factors must be taken into account during the vaccines introduction. © 2019 The AuthorsKeyword
Antenatal careCountry-level policy making
Global policies
Health policies
Healthcare providers
Immunisation
Introduction
Maternal Immunization
Pharmacovigilance
Pregnancy
Program
Regulatory
Safety
Vaccination coverage
Vaccine hesitancy
Vaccines
Identifier to cite or link to this item
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85065089129&origin=inward; http://hdl.handle.net/10713/10071ae974a485f413a2113503eed53cd6c53
10.1016/j.vaccine.2019.04.075
Scopus Count
Collections
Related articles
- Lessons learnt from enrolment and follow up of pregnant women and their infants in clinical trials in South Africa, a low-middle income country.
- Authors: Cutland CL, Cunnington M, Olugbosi M, Jones SA, Hugo A, Maharaj K, Slobod K, Madhi SA
- Issue date: 2015 Nov 25
- Key considerations for successful implementation of maternal immunization programs in low and middle income countries.
- Authors: Krishnaswamy S, Lambach P, Giles ML
- Issue date: 2019
- Strengthening vaccination policies in Latin America: an evidence-based approach.
- Authors: Tapia-Conyer R, Betancourt-Cravioto M, Saucedo-Martínez R, Motta-Murguía L, Gallardo-Rincón H
- Issue date: 2013 Aug 20
- Maternal immunization in Malawi: A mixed methods study of community perceptions, programmatic considerations, and recommendations for future planning.
- Authors: Fleming JA, Munthali A, Ngwira B, Kadzandira J, Jamili-Phiri M, Ortiz JR, Lambach P, Hombach J, Neuzil KM, Stepanchak M, Bhat N
- Issue date: 2019 Jul 26
- Tuberculosis
- Authors: Bloom BR, Atun R, Cohen T, Dye C, Fraser H, Gomez GB, Knight G, Murray M, Nardell E, Rubin E, Salomon J, Vassall A, Volchenkov G, White R, Wilson D, Yadav P, Holmes KK, Bertozzi S, Bloom BR, Jha P
- Issue date: 2017 Nov 3